Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects

University of Calgary

$80,716.00

Bioreactor production of human embryonic stem cell derived osteoblasts and chondrocytes

EF 2009-10

Résumé
Musculoskeletal ailments, including osteoporosis and bone and joint injuries, currently affect several hundred million people worldwide. These conditions result in a decreased quality of life for many people and a considerable ongoing cost to health care systems. Recently, tissue engineering has emerged as a potential new alternative for treating affected individuals. Tissue engineering involves combining cells with a scaffold support to generate functional replacement tissues. In particular, the use of embryonic stem cells is being investigated as a potential source of cells to regenerate tissues. Embryonic stem cells (ESCs) can divide to form many cells, and are pluripotent, meaning mat they possess the ability to form any tissue type in the body. Recently, we have successfully generated bone and cartilage tissue in small-scale stationary cultures of mouse ESCs, which we have begun to integrate into biodegradable scaffolds. As a result of the high level of tissue demand for clinical use, many more cells will be required. We will use our success with the model (mouse) system as a basis for the proposed research, which will examine the large-scale production and differentiation, of human ESCs in computer-controlled bioreactors. Our long-term goal will be to apply our approach to the human clinical setting. Hence, one of the outcomes of this work, successful production of bone and cartilage tissue, will be highly beneficial to the thousands of Canadians who suffer from joint injuries and diseases. Our work will have worldwide implications towards the progress and advancement of the field of tissue engineering. Other immediate outcomes of the research will include the coalescence of a multidisciplinary team with expertise in bioengineering, engineering physics, biophysics, biology, and mathematics around a unique medical problem and the development of a unique training program involving biomedical engineering and stem cell biology.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
338157-2007
Name nom
Kallos, Michael
Department département
Chemical and Petroleum Engineering
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2007
Award amount
80716
Program id
CHRPJ
Program nane en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
3
Nb partie
3
Application title
Bioreactor production of human embryonic stem cell derived osteoblasts and chondrocytes
Keyword
NA
Application summary
Musculoskeletal ailments, including osteoporosis and bone and joint injuries, currently affect several hundred million people worldwide. These conditions result in a decreased quality of life for many people and a considerable ongoing cost to health care systems. Recently, tissue engineering has emerged as a potential new alternative for treating affected individuals. Tissue engineering involves combining cells with a scaffold support to generate functional replacement tissues. In particular, the use of embryonic stem cells is being investigated as a potential source of cells to regenerate tissues. Embryonic stem cells (ESCs) can divide to form many cells, and are pluripotent, meaning mat they possess the ability to form any tissue type in the body. Recently, we have successfully generated bone and cartilage tissue in small-scale stationary cultures of mouse ESCs, which we have begun to integrate into biodegradable scaffolds. As a result of the high level of tissue demand for clinical use, many more cells will be required. We will use our success with the model (mouse) system as a basis for the proposed research, which will examine the large-scale production and differentiation, of human ESCs in computer-controlled bioreactors. Our long-term goal will be to apply our approach to the human clinical setting. Hence, one of the outcomes of this work, successful production of bone and cartilage tissue, will be highly beneficial to the thousands of Canadians who suffer from joint injuries and diseases. Our work will have worldwide implications towards the progress and advancement of the field of tissue engineering. Other immediate outcomes of the research will include the coalescence of a multidisciplinary team with expertise in bioengineering, engineering physics, biophysics, biology, and mathematics around a unique medical problem and the development of a unique training program involving biomedical engineering and stem cell biology.